An approved product is a clear starting point
Some peptide products have U.S. approval for specific conditions. Semaglutide (Ozempic, Wegovy) is an example.
The drug name alone does not settle whether a different preparation or advertised use has the same status.
Prescription-only means the medicine needs an order from a health professional licensed to write it. Dispensing it without that order breaks U.S. law.
Custom preparation has conditions
Compounding is making a medicine to order. It can serve a patient need, but the ingredient and the preparation still have to meet the applicable rules.
Regular pharmacies cannot routinely make a close copy of a medicine already on the market. An exception applies when the prescriber judges that the change would make an important difference to the individual patient.
For example, a custom medicine may leave out an ingredient the patient is allergic to.
Ask what change you need and why it matters for you.
A lower price is not that patient-specific difference.
Research wording does not create a treatment route
FDA is the Food and Drug Administration. In its warning letters, FDA has treated research-labelled products advertised for human use as unapproved drugs. Those letters allege unlawful sales by the firms involved; they are not court judgments.
What a product is offered to do helps determine its legal status. A research label does not cancel claims about changing the body or treating disease.
The care rules also depend on the state
For an online visit, the prescriber must have authority to practise where the patient is located. State rules for the assessment can differ.